| Randomized, double-blind, placebo-controlled, single-dose, multiple-dose trial for Futagliptin benzoic acid in T2DM to evaluate tolerance, pharmacokinetics and pharmacodynamics | Randomized, double-blind, placebo-controlled, single-dose, multiple-dose trial for Futagliptin benzoic acid in T2DM to evaluate tolerance, pharmacokinetics and pharmacodynamics | ChiCTR1800018169 |
| Comparative assessment of the absorption of a generic formulation of 75 mg 4-[1-(5,6,7,8-tetrahydro-3,5,5,8,8-pentamethyl-2- naphthalenyl) ethenyl] benzoic acid capsule against the innovator 75 mg 4-[1-(5,6,7,8-tetrahydro-3,5,5,8,8-pentamethyl-2- naphthalenyl) ethenyl] benzoic acid capsule conducted under fed conditions in healthy volunteers. | A single dose, randomized, blinded, pharmacokinetic study of a generic formulation of 75 mg 4-[1-(5,6,7,8-tetrahydro-3,5,5,8,8-pentamethyl-2- naphthalenyl) ethenyl] benzoic acid capsule in a 2 way crossover comparison against the innovator 75 mg 4-[1-(5,6,7,8-tetrahydro-3,5,5,8,8-pentamethyl-2- naphthalenyl) ethenyl] benzoic acid capsule conducted under fed conditions in healthy volunteers. | ACTRN12620000825954 |
| Randomized, double-blind, placebo-controlled, multicentre, parallel-group study of Futagliptin benzoic acid in T2DM | Randomized, double-blind, placebo-controlled, multicentre, parallel-group study of Futagliptin benzoic acid in T2DM | ChiCTR1800017909 |
| Benzoates - an Obesogenic Endocrine Disrupting Chemical | Benzoic Acid in Beverages: Establishing a Link Between Urinary Metabolites, Metabolic Dysregulation and Weight Loss Failure | NCT03190785 |
| Study of the effect of benzoic acid on glutamic acid | Effects of sodium benzoate on glutamate and glutathione levels in patients with treatment-resistant schizophrenia | JPRN-jRCTs031200050 |
| Pharmacokinetics study to compare Futagliptin Benzoic Acid Tablets with Futagliptin Benzoic Acid Capsules | Pharmacokinetics study to compare Futagliptin Benzoic Acid Tablets with Futagliptin Benzoic Acid Capsules | ChiCTR1800018170 |
